CTRI/2020/12/029746已完成未知
A prospective, post market, non-interventional observational, open label, single arm, single center study to validate the clinical safety and performance of Intraskan DC
Skanray Technologies Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Male and female subjects of all age groups.
- •Subjects or legally authorized representatives or guardians on behalf of the subject who are able and willing to provide written informed consent to participate in this clinical investigation.
排除标准
- •Pregnant or suspected to be pregnant based on the opinion of a physician.
- •Infant of age less than 1 year.
研究者
相似试验
已完成
4 期
Post Market Clinical Follow Up of Skanray s Patient MonitorsCTRI/2022/05/042811Skanray Technologies Limited
已完成
4 期
Post Market Clinical Follow Up Investigation of SKAN CCTRI/2020/12/029836Skanray Technologies Pvt Ltd
已完成
4 期
Post Market Clinical Follow Up of SkanRespiro Plus and PranaaCTRI/2022/05/042810Skanray Technologies Limited
已完成
4 期
Post Market Clinical Follow Up Investigation of Skanmobile and Skanmobile DRCTRI/2020/09/028059Skanray Technologies Pvt Ltd
已完成
4 期
Post Market Clinical Follow Up Investigation of microSKACTRI/2020/12/029799Skanray Technologies Pvt Ltd